Holen Sie sich die Stockscreener-App
4.11
3.53%
0.14
Handel nachbörslich:
4.17
0.06
+1.46%
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
SANA Should I Buy - Intellectia AI
Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative? - Sahm
Sana to show first-in-human islet transplant data without immunosuppression - Stock Titan
Citizens reiterates Sana Biotechnology stock rating on IND filing By Investing.com - Investing.com Canada
Sana Biotechnology, Inc.(NasdaqGS:SANA) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000 Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000E Value Benchmark - marketscreener.com
Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 2000 Value Benchmark - marketscreener.com
Join Class Action to Recover Losses from Sana Biotechnology, Inc - The National Law Review
Lost Money on Sana Biotechnology, Inc. (SANA)? Contact Levi & Korsinsky to Join Class Action Before May 20, 2025 - The National Law Review
Enterprise value to EBIT forward of Sana Biotechnology, Inc. – NASDAQ:SANA - TradingView
SANA BIOTECHNOLOGY INC (SANA) Stock Chart - ChartMill
Price to earnings forward of Sana Biotechnology, Inc. – NASDAQ:SANA - TradingView
Sana Biotechnology, Inc. Actuals & Estimates (NASDAQ:SANA) - TradingView
SANA Forecast — Price Target — Prediction for 2027 - TradingView
SANA News | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sana Biotechnology Inc (SANA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sana Biotechnology Inc (SANA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sana Biotechnology Inc (SANA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sana Biotechnology Inc (SANA) Institutional Confidence - TradingKey
Sana Biotechnology Inc (SANA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sana Biotechnology Inc (SANA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sana Biotechnology Inc (SANA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside - TradingView
Sana Biotechnology raises $69M through ATM share sale - MSN
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor - Yahoo Finance
Sana Biotechnology (SANA) Holds Steady at $2.82 Amid Key Technical RangePut Wall - dars.gov.et
SANA: Gene-modified islet and in vivo CAR T therapies advance toward pivotal trials and key data in 2024 - TradingView
Sana Biotechnology, Inc. - MLQ.ai
SANA SEC FilingsSana Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Bilenker Joshua H. - Moomoo
Sana Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT - Moomoo
Sana Biotechnology Shareholders Reelect Directors and Ratify Auditor - TipRanks
Sana Biotechnology (SANA) director awarded options for 90,000 shares at $2.96 - Stock Titan
Sana Biotechnology (SANA) director granted 90,000 stock options at $2.96 strike - Stock Titan
Director Michelle Seitz gets 90,000 Sana (SANA) stock options - Stock Titan
Sana Biotechnology (SANA) grants director 90,000 stock options at $2.96 - Stock Titan
Sana Biotechnology (SANA) director receives 90,000-share stock option grant - Stock Titan
Sana Biotechnology (SANA) director granted 90,000 stock options at $2.96 - Stock Titan
Sana (SANA) director awarded 90,000 stock options vesting in 2027 - Stock Titan
Sana Biotechnology (SANA) shareholders elect directors, ratify Ernst & Young LLP - Stock Titan
SANA: Hypoimmune cell therapy and in vivo CAR T trials to start this year, with data expected in 12 months - TradingView
SANA Stock Price, Quote & Chart | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
Law firm probes Sana Biotech officers for possible shareholder duty breaches - Pluang
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Stream Sana Biotechnology's June investor talks live online - Stock Titan
Seattle InnoSana and Bothell I Following up with ZenLedger - The Business Journals
Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum - Quantisnow
SANASana Biotechnology Inc Stock Price and Quote - Finviz
Sana Biotechnology to present updates at two major healthcare investor conferences in June 2026 - Pluang
Sana Biotechnology to Present at June 2026 Investor Conferences - The Manila Times
RA Capital affiliates report 18.75M Sana Biotechnology shares (NASDAQ: SANA) - Stock Titan
Sana Biotechnology | SCHEDULE 13G: Others - Moomoo
Morgan Stanley Maintains Sana Biotechnology(SANA.US) With Buy Rating, Cuts Target Price to $3.07 - Moomoo
InvestingPro Fair Value spotted Sana Biotech overvaluation early By Investing.com - Investing.com Canada
1.18%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):